Abstract

Purpose: Development of aortic insufficiency (AI) in patients (pts) during continuous flow LVAD support is a well known phenomenon that can lead to ineffective LVAD output. Current literature reports an average AI progression by 0.7 grade at 6 months (mo). We hypothesized that optimal medical therapy (MT) together with lowering the LVAD speed to allow aortic valve (AV) opening delays development of significant AI. Methods and Materials: Charts and echocardiograms (echos) of 40 LVAD pts were reviewed for demographics and medications. Medications were uptitrated to MAP of 60-80mmHg. VAD speed (RPM) was reduced according to our outpatient VAD protocol and collected at 1 and 6 mo. Echos were reviewed at baseline (pre LVAD), 1 and 6 mo for left ventricular end diastolic dimensions (LVEDD)(cm), AV opening, presence/ absence of AI. AI was graded: O-none, 0.5-trace,1-mild,1.5-mild-moderate, 2-moderate, 2.5-moderate-severe, 3-severe. Results: Forty pts, mean age 58, were included in the study. At 6 mo 38/40 (93%) pts were receiving beta blocker (BB), 30/40 (73%) ACE-I/ARB, 27/40 (66%) aldosterone receptor blocker (ALDOBL). Fifty six percent of pts achieved half of maximal daily dose of ACE-I/ARB, 45% BB and 53% ALDOBL. Twenty nine out of 40 (71%) pts were on furosemide, mean dose 32 mg. At baseline mean LVEDD was 6.8, AI present in 12/40 pts (30%), mean grade 0.3. At 1 mo LVEDD decreased to a mean 5, AI present in 6/22 (27%) pts, mean grade 0.27. At 6 mo LVEDD was the same, mean 5.1, AI present in 8/19 (42%) pts. Mean grade increased from 0.27 to 0.4 (p 0.3). Mean LVAD speed at 1 mo was 9190 and decreased to 8840 at 6 mo (p 0.001). At 1 mo AV opened with every beat in 33% pts, partially opened in 8%, did not open in 54%. At 6 mo AV opened with every beat in 36% pts, partially opened in 21%, did not open in 43%. Conclusions: Our results suggest slower progression in the AI grade at 6 mo in LVAD pts, than reported to date. An early strategy of decreasing VAD speed combined with optimization of MT may account for this difference and possibly improve long term survival.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.